Interventional Cryoneurolysis: What Is the Same, What Is Different, What Is New? von Bittman, Ross W., Behbahani, Keywan, Gonzalez, Felix, Prologo, J. David

Volltext

Percutaneous Image-Guided Cryoneurolysis von Bittman, Ross W, Peters, Gail L, Newsome, Janice M, Friedberg, Eric B, Mitchell, Jason W, Knight, Jacquelyn M, Prologo, J David

Volltext

Global Approach to the Patient with Pain in Interventional Radiology von Bittman, Ross W., Friedberg, Eric B., Fleishon, Howard B., Prologo, J. David

Volltext

p120 Catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas von Hendley, Audrey M., Provost, Elayne, Bailey, Jennifer M., Wang, Yue J., Cleveland, Megan H., Blake, Danielle, Bittman, Ross W., Roeser, Jeffrey C., Maitra, Anirban, Reynolds, Albert B., Leach, Steven D.

Volltext

Probes for Narcotic Receptor Mediated Phenomena. 41. Unusual Inverse μ-Agonists and Potent μ-Opioid Antagonists by Modification of the N-Substituent in Enantiomeric 5-(3-Hydroxyphe... von Cheng, Kejun, Lee, Yong Sok, Rothman, Richard B, Dersch, Christina M, Bittman, Ross W, Jacobson, Arthur E, Rice, Kenner C

Volltext

Percutaneous Image-guided Cryoneurolysis: Applications and Techniques von Sag, Alan Alper, Bittman, Ross, Prologo, Frank, Friedberg, Eric B., Nezami, Nariman, Ansari, Sana, Prologo, J. David

Volltext

Artificial Intelligence Algorithm Improves Radiologist Performance in Skeletal Age Assessment: A Prospective Multicenter Randomized Controlled Trial von Eng, David K, Khandwala, Nishith B, Long, Jin, Fefferman, Nancy R, Lala, Shailee V, Strubel, Naomi A, Milla, Sarah S, Filice, Ross W, Sharp, Susan E, Towbin, Alexander J, Francavilla, Michael L, Kaplan, Summer L, Ecklund, Kirsten, Prabhu, Sanjay P, Dillon, Brian J, Everist, Brian M, Anton, Christopher G, Bittman, Mark E, Dennis, Rebecca, Larson, David B, Seekins, Jayne M, Silva, Cicero T, Zandieh, Arash R, Langlotz, Curtis P, Lungren, Matthew P, Halabi, Safwan S

Volltext

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies von Oaks, Joshua J., Santhanam, Ramasamy, Walker, Christopher J., Roof, Steve, Harb, Jason G., Ferenchak, Greg, Eisfeld, Ann-Kathrin, Van Brocklyn, James R., Briesewitz, Roger, Saddoughi, Sahar A., Nagata, Kyosuke, Bittman, Robert, Caligiuri, Michael A., Abdel-Wahab, Omar, Levine, Ross, Arlinghaus, Ralph B., Quintas-Cardama, Alfonso, Goldman, John M., Apperley, Jane, Reid, Alistair, Milojkovic, Dragana, Ziolo, Mark T., Marcucci, Guido, Ogretmen, Besim, Neviani, Paolo, Perrotti, Danilo

Volltext

FTY720 Restores PP2A Tumor Suppressor Activity in Polycythemia Vera CD34+ Progenitors Through Inhibition of Jak2 V617F- and PI-3Kγ-Dependent SET Serine Phosphorylation and Enhancem... von Oaks, Joshua J, Mukhopadhyay, A., Santhanam, Ramasamy, Saddoughi, S. A, Neviani, Paolo, Harb, Jason G, Ogretmen, Besim, Bittman, Robert, Levine, Ross L, Quintás-Cardama, Alfonso, Marcucci, Guido, Perrotti, Danilo

Volltext

Research needs for conserving California's rare plants von Skinner, M.W. (California Native Plant Society, Sacramento, CA.), Tibor, D.P, Bittman, R.L, Ertter, B, Ross, T.S, Boyd, S, Sanders, A.C, Shevock, J.R, Taylor, D.W

Volltext